Experimental heart failure in rats: Effects on cardiovascular circadian rhythms and on myocardial β-adrenergic signaling

Cardiovascular Research

Volumn 47, Issue 2, 2000, Pages 350-358

  Witte, Klaus ^a   Hu, Kai ^b   Swiatek, Johanna ^a   Müssig, Claudia ^a   Ertl, Georg ^b   Lemmer, Björn ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adrenergic (ant)agonists; Blood pressure; Heart failure; Receptors

Indexed keywords

ADENYLATE CYCLASE; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; RADIOLIGAND; RECEPTOR SUBTYPE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MONITORING; CIRCADIAN RHYTHM; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DESENSITIZATION; ENZYME ACTIVATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE FAILURE; HEART RATE; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SYMPATHETIC TONE; TELEMETRY;

5'-NUCLEOTIDASE; ADENYLATE CYCLASE; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CIRCADIAN RHYTHM; FEMALE; GTP-BINDING PROTEINS; HEART FAILURE, CONGESTIVE; HEART RATE; MYOCARDIUM; RADIOLIGAND ASSAY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA; SIGNAL TRANSDUCTION; STATISTICS, NONPARAMETRIC; SYMPATHETIC NERVOUS SYSTEM; TELEMETRY;

EID: 0033894960     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(00)00099-7     Document Type: Article

References (33)

1. Francis G.S., Cohn J.N., Johnson G., Rector T.S., Goldman S., Simon A. Plasma norepinephrine, plasma renin activity, and congestive heart failure - relations to survival and the effects of therapy in V-HeFT-II. Circulation. 87:(Suppl. VI):1993;40-48.
2. Kaye D.M., Lefkovits J., Jennings G.L., Bergin P., Broughton A., Esler M.D. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 26:1995;1257-1263.
3. Guidelines for the evaluation and management of heart failure. Circulation. 92:1995;2764-2784.
4. Guidelines: the treatment of heart failure. Eur Heart J. 18:1997;736-753.
5. Caruana M.P., Lahiri A., Cashman P.M.M., Altman D.G., Raftery E.B. Effects of chronic congestive heart failure secondary to coronary artery disease on the circadian rhythm of blood pressure and heart rate. Am J Cardiol. 62:1988;755-759.
6. Portaluppi F., Montanari L., Ferlini M., et al. Consistent changes in the circadian rhythms of blood pressure and atrial natriuretic peptide in congestive heart failure. Chronobiol Internat. 8:1991;432-439.
7. Giles T.D., Roffidal L., Quiroz A., Sander G., Tresznewsky O. Circadian variation in blood pressure and heart rate in nonhypertensive congestive heart failure. J Cardiovasc Pharmacol. 28:1996;733-740.
8. Post S.R., Hammond H.K., Insel P.A. β-Adrenergic receptors and receptor signaling in heart failure. Annu Rev Pharmacol Toxicol. 39:1999;343-360.
9. Dzimiri N. Regulation of β-adrenoceptor signaling in cardiac function and disease. Pharmacol Rev. 51:1999;465-501.
10. Pfeffer M.A., Pfeffer J.M., Fishbein M.C., et al. Myocardial infarct size and ventricular function in rats. Circ Res. 44:1979;503-512.
11. Hu K., Gaudron P., Ertl G. Long-term effects of β-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction. J Am Coll Cardiol. 31:1998;692-700.
12. Lemmer B., Mattes A., Böhm M., Ganten D. Circadian blood pressure variation in transgenic hypertensive rats. Hypertension. 22:1993;97-101.
13. Witte K., Zuther P., Lemmer B. Analysis of telemetric time series data for periodic components using DQ-FIT. Chronobiol Internat. 14:1997;561-574.
14. Witte K., Schnecko A., Hauth D., Wirzius S., Lemmer B. Effects of chronic application of propranolol on β-adrenergic signal transduction in heart ventricles from myopathic BIO TO2 and control hamsters. Br J Pharmacol. 125:1998;1033-1041.
15. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. J Biol Chem. 193:1951;265-275.
16. Lomb N.R. Least-squares frequency analysis of unequally spaced data. Astrophys Space Sci. 39:1976;447-462.
17. Mattes A., Witte K., Hohmann W., Lemmer B. PHARMFIT - a nonlinear fitting program for pharmacology. Chronobiol Internat. 8:1991;460-476.
18. Ackermann H. BiAS. Biometrische Analyse von Stichproben. 1997;Epsilon-Verlag, Hochheim-Darmstadt.
19. Yamamoto J., Ohyanagi M., Morita M., Iwasaki T. β-Adrenoceptor-G protein-adenylate cyclase complex in rat hearts with ischemic heart failure produced by coronary artery ligation. J Mol Cell Cardiol. 26:1994;617-626.
20. Chasteney E.A., Liang C.S., Hood W.B. β-Adrenoceptor and adenylate cyclase function in the infarct model of rat heart failure. Proc Soc Exp Biol Med. 200:1992;90-94.
21. Warner A.L., Bellah K.L., Raya T.E., Roeske W.R., Goldman S. Effects of β-adrenergic blockade on papillary muscle function and the β-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. Circulation. 86:1992;1584-1595.
22. Sanbe A., Takeo S. Long-term treatment with angiotensin I-converting enzyme inhibitors attenuates the loss of cardiac β-adrenoceptor responses in rats with chronic heart failure. Circulation. 92:1995;2666-2675.
23. Sethi R., Dhalla K.S., Beamish R.E., Dhalla N.S. Differential changes in left and right ventricular adenylyl cyclase activities in congestive heart failure. Am J Physiol. 272:1997;H884-H893.
24. Gu X.H., Kompa A.R., Summers R.J. Regulation of β-adrenoceptors in a rat model of cardiac failure: effect of perindopril. J Cardiovasc Pharmacol. 32:1998;66-74.
25. Ganguly P.K., Dhalla K.S., Shao Q., Beamish R.E., Dhalla N.S. Differential changes in sympathetic activity in left and right ventricles in congestive heart failure after myocardial infarction. Am Heart J. 133:1997;340-345.
26. Bristow M.R., Minobe W., Rasmussen R., Larrabee P., Skerl L., Klein J.W., Anderson F.L., Murray J., Mestroni L., Karwande S.V., Fowler M., Ginsburg R. β-Adrenergic neuroeffector abnormalities in the failing human heart are produced by local, rather than systemic mechanisms. J Clin Invest. 89:1992;803-815.
27. Lemmer B., Saller R. Influence of light and darkness on the turnover of noradrenaline in the rat heart. Naunyn-Schmiedeberg's Arch Pharmacol. 282:1974;75-84.
28. Makino M., Hayashi H., Takezawa H., Hirai M., Saito H., Ebihara S. Circadian rhythms of cardiovascular functions are modulated by the baroreflex and the autonomic nervous system in the rat. Circulation. 96:1997;1667-1674.
29. Teerlink J.R., Clozel J.P. Hemodynamic variability and circadian rhythm in rats with heart failure: role of locomotor activity. Am J Physiol. 264:1993;H2111-H2118.
30. 1-adrenoceptors. Am J Physiol. 271:1996;H1465-H1472.
31. sα. Circ Res. 82:1998;416-423.
32. Hodsman G.P., Kohzuki M., Howes L.G., Sumithran E., Tsunoda K., Johnston C.I. Neurohumoral responses to chronic myocardial infarction in rats. Circulation. 78:1988;376-381.
33. Okuguchi T., Osanai T., Kamada T., Kimura M., Takahashi K., Okumura K. Significance of sympathetic nervous system in sodium-induced nocturnal hypertension. J Hypertens. 17:1999;947-957.